{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:37:07Z","timestamp":1760549827600,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Ministerio de Econom\u00eda y Competitividad (MINECO)","award":["PI12\/01552"],"award-info":[{"award-number":["PI12\/01552"]}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2010\/BMD-2344"],"award-info":[{"award-number":["S2010\/BMD-2344"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MINECO (Instituto de Salud Carlos III, RETICS Red de Biobancos","award":["PT13\/0010\/0012"],"award-info":[{"award-number":["PT13\/0010\/0012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mutations in Human Epidermal Growth Factor Receptors (HER) are associated with poor prognosis of several types of solid tumors. Although HER-mutation detection methods are currently available, such as Next-Generation Sequencing (NGS), alternative pyrosequencing allow the rapid characterization of specific mutations. We developed specific PCR-based pyrosequencing assays for identification of most prevalent HER2 and HER3 mutations, including S310F\/Y, R678Q, L755M\/P\/S\/W, V777A\/L\/M, 774-776 insertion, and V842I mutations in HER2, as well as M91I, V104M\/L, D297N\/V\/Y, and E332E\/K mutations in HER3. We tested 85 Formalin Fixed and Paraffin Embbeded (FFPE) samples and we detected three HER2-V842I mutations in colorectal carcinoma (CRC), ovarian carcinoma, and pancreatic carcinoma patients, respectively, and a  HER2-L755M mutation in a CRC specimen. We also determined the presence of a  HER3-E332K mutation in an urothelial carcinoma sample, and two HER3-D297Y mutations, in both gastric adenocarcinoma and CRC specimens. The D297Y mutation was previously detected in breast and gastric tumors, but not in CRC. Moreover, we found a not-previously-described HER3-E332E synonymous mutation in a retroperitoneal leiomyosarcoma patient. The pyrosequencing assays presented here allow the detection and characterization of specific HER2 and HER3 mutations. These pyrosequencing assays might be implemented in routine diagnosis for molecular characterization of HER2\/HER3 receptors as an alternative to complex NGS approaches.<\/jats:p>","DOI":"10.3390\/ijms160819447","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T05:43:13Z","timestamp":1439876593000},"page":"19447-19457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma"],"prefix":"10.3390","volume":"16","author":[{"given":"Paula","family":"Gonz\u00e1lez-Alonso","sequence":"first","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chamizo","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Moreno","sequence":"additional","affiliation":[{"name":"Translational Oncology Division, Oncohealth Institute, Fundaci\u00f3n Jim\u00e9nez D\u00edaz Hospital, Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Madoz-G\u00farpide","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Carvajal","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Daoud","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Zazo","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Mart\u00edn-Aparicio","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-4213","authenticated-orcid":false,"given":"Ion","family":"Crist\u00f3bal","sequence":"additional","affiliation":[{"name":"Translational Oncology Division, Oncohealth Institute, Fundaci\u00f3n Jim\u00e9nez D\u00edaz Hospital, Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Rinc\u00f3n","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Garc\u00eda-Foncillas","sequence":"additional","affiliation":[{"name":"Translational Oncology Division, Oncohealth Institute, Fundaci\u00f3n Jim\u00e9nez D\u00edaz Hospital, Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rojo","sequence":"additional","affiliation":[{"name":"Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundaci\u00f3n Jim\u00e9nez D\u00edaz (IIS-FJD, UAM), Avda. Reyes Cat\u00f3licos 2, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ErbB receptors and cancer: The complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","article-title":"An open-and-shut case? Recent insights into the activation of EGF\/ErbB receptors","volume":"12","author":"Burgess","year":"2003","journal-title":"Mol. Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: Revisiting ErbB2 and discovering ErbB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1309\/AJCPST1CTHZS3PSZ","article-title":"EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry","volume":"133","author":"Sholl","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2899","article-title":"Synonymous but not the same: The causes and consequences of codon bias","volume":"12","author":"Plotkin","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.6026\/97320630010256","article-title":"A cross talk between codon usage bias in human oncogenes","volume":"10","author":"Mazumder","year":"2014","journal-title":"Bioinformation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.18632\/oncotarget.1946","article-title":"Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms","volume":"5","author":"Wheler","year":"2014","journal-title":"Oncotarget"},{"key":"ref_9","first-page":"86","article-title":"Activating mutations in ErbB2 and their impact on diagnostics and treatment","volume":"3","author":"Greulich","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccr.2013.04.012","article-title":"Oncogenic ErbB3 mutations in human cancers","volume":"23","author":"Jaiswal","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/1471-2407-10-660","article-title":"KRAS analysis in colorectal carcinoma: Analytical aspects of pyrosequencing and allele-specific PCR in clinical practice","volume":"10","author":"Sundstrom","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2012.47.2787","article-title":"Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors","volume":"32","author":"Gandhi","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_13","unstructured":"cBioPortal for cancer genomics. Available online: http:\/\/www.cbioportal.org\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490, 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1479-5876-9-119","article-title":"Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine","volume":"9","author":"Holbrook","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_19","unstructured":"Cosmic: Catalogue of somatic mutations in cancer. Available online: http:\/\/cancer.sanger.ac.uk\/cancergenome\/projects\/cosmic."},{"key":"ref_20","unstructured":"NCBI (Nacional center for biotechnology information) dbSNP: Database of single nucleotide polymorphisms (SNPs), Available online: http:\/\/www.ncbi.nlm.nih.gov\/snp."},{"key":"ref_21","unstructured":"UniProt: Universal protein resource. Available online: http:\/\/www.uniprot.org\/uniprot\/P21860."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cell.2014.02.037","article-title":"Silent mutations make some noise","volume":"156","author":"Zheng","year":"2014","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","article-title":"Synonymous mutations frequently act as driver mutations in human cancers","volume":"156","author":"Supek","year":"2014","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.2443975","article-title":"A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides","volume":"238","author":"Prober","year":"1987","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-13-114","article-title":"Detection and characterization of classical and \u201cuncommon\u201d exon 19 epidermal growth factor receptor mutations in lung cancer by pyrosequencing","volume":"13","author":"Righi","year":"2013","journal-title":"BMC Cancer"},{"key":"ref_26","unstructured":"NCBI Nacional center for biotechnology information, Available online: http:\/\/www.ncbi.nlm.nih.gov\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/8\/19447\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:50:45Z","timestamp":1760215845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/8\/19447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["ijms160819447"],"URL":"https:\/\/doi.org\/10.3390\/ijms160819447","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}